|
Volumn 81, Issue , 2008, Pages
|
Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidence.
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRHEUMATIC AGENT;
BIOLOGICAL MARKER;
BIOLOGICAL PRODUCT;
EVIDENCE BASED MEDICINE;
HOSPITALIZATION;
HUMAN;
PATIENT SELECTION;
PRACTICE GUIDELINE;
PREDICTION AND FORECASTING;
REMISSION;
REVIEW;
RHEUMATOID ARTHRITIS;
RISK ASSESSMENT;
TREATMENT FAILURE;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
BIOLOGICAL MARKERS;
BIOLOGICAL PRODUCTS;
EVIDENCE-BASED MEDICINE;
HUMANS;
PATIENT SELECTION;
PRACTICE GUIDELINES AS TOPIC;
PREDICTIVE VALUE OF TESTS;
REMISSION INDUCTION;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
TREATMENT FAILURE;
|
EID: 69249229882
PISSN: 03800903
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (13)
|
References (150)
|